The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Shanta Gold Non-Executive Sells Stake

Fri, 23rd Jan 2015 13:36

Director Dealings Summary - Week Ended January 23        
Company Name Position Buy or Sell Number of Shares Resulting Holding *Note
1PM Ron Russell Non-Executive Director Buy 40,907 7.3 million After posting positive results
Aberdeen Asset Management Richard Mully Non-Executive Director Buy 15,000 30,000  
Amati VCT Paul Jourdan Manager Buy 34,698 282,506  
Bankers Investment Trust David Wild Non-Executive Director Buy 8,403 12,803  
BlueRock Diamonds John Kilham CTO Buy 100,000 250,000  
British Land Co Charles Maudsley Director Sold 50,000 Undisclosed  
Cloudbuy Lyn Duncan CEO Buy 20,000 21.1 million 2 weeks after signing new website deal
Enteq Upstream David Steel CFO Buy 12,659 81,240 3 days after profit warning
e-Therapeutics Steve Medlicott  CFO Buy 150,000 250,000  
Flowgroup Nigel Canham CFO Buy 68,400 68,400 First purchase
Fulcrum Utility Services Stephen Gutteridge Non-Executive Director Buy 125,000 529,166 Week after deciding to take its operational delivery in-house
Games Workshop Elaine O'Donnell Non-Executive Director Buy 1,500 1,500 First purchase
Hilton Food Robert Watson CEO Sold 90,000 2.9 million 11 days after posting positive results
Judges Scientific Alex Hambro Chairman Sold 15,000 77,500 Same day as company bought Armfield Ltd for GBP8.3 million
Kingfisher Véronique Laury CEO Buy 100,000 Undisclosed  
Mithril Capital Rodger Sargent Non-Executive Director Buy 675,000 5.4 million  
Lamprell John Macdonald Senior Manager Buy 19,185 51,185 1 week after profit warning
Leed Resources Charles Zorab Non-Executive Director Buy 3.3 million 3.3 million 2 weeks after company agreed to invest in limestone miner
Lekoil Gregory Eckersley Non-Executive Director Buy 45,000 2.8 million Same day as project in Nigeria declared "robust"
London Capital Group Charles-Henri Sabet Chairman Buy 250,000 1.7 million Day after loan note conversions announced
Proton Power Thomas Melczer Business Development Director Sold 250,000 250,000 2 days after reporting a loss
REA Holdings Irene Chia Non-Executive Director Buy 1,000 Undisclosed  
Renew Holdings Brian May CEO Sold 350,000 494,193 Sold from his wife's shareholding
Rosslyn Data Tech Hugh Cox Director Buy 38,838 9.5 million  Same day as company posted a loss
Shanta Gold Luke Leslie Non-Executive Director Sold 3.3 million nil Sold  entire stake day after positive Q4 update
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event.
When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam    
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
20 Mar 2018 16:14

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 21 March KingfisherFull Year ResultsAlpha FXFull Year In SportFull 22

Read more
9 Jan 2017 08:49

E-Therapeutics Hires Amgen Director As New Chief Executive

Read more
6 Oct 2016 11:23

DIRECTOR DEALINGS: e-Therapeutics Non-Executive Acquires Shares

Read more
14 Sep 2016 11:23

e-Therapeutics Development Director Steve Self To Step Down

Read more
13 Jul 2016 09:13

E-Therapeutics Chairman Takes On Executive Duties As CEO Steps Down

Read more
1 Jun 2016 08:03

e-Therapeutics Offer For Searchbolt Now Wholly Unconditional

Read more
25 May 2016 08:18

e-Therapeutics Focused On Validation Of Drug Discovery Platform

Read more
18 May 2016 15:05

AGM, EGM Calendar - Week Ahead

Read more
12 May 2016 11:13

DIRECTOR DEALINGS: E-Therapeutics Non-Executive Acquires Shares

Read more
11 May 2016 09:06

e-Therapeutics To Buy Searchbolt For GBP2.3 Million (ALLISS)

Read more
22 Mar 2016 11:40

E-Therapeutics Loss Widens As Active Projects Increase

Read more
15 Mar 2016 16:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
15 Feb 2016 10:43

WINNERS & LOSERS SUMMARY: Reckitt Benckiser Results Please Investors

Read more
15 Feb 2016 09:45

E-Therapeutics depression drug trials miss targets

(ShareCast News) - Drug trials results for e-Therapeutics' depression treatment were not as successful as had been hoped, sending shares in the company sharply lower. Phase IIb clinical trials of the company's ETS6103 product did not achieve the aim of matching the efficacy of existing tricyclic ant

Read more
15 Feb 2016 08:20

E-Therapeutics Shares Drop As ETS6103 Trials Miss Primary Endpoint

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.